Pneumocystis carinii continues to represent an important complication of in
dividuals with compromised immunity. P. carinii interacts with immune and n
on-immune cells in the lung and mediates lung injury through a variety of m
echanisms. CD4+ T lymphocytes are the cornerstone in defence against P. car
inii. Recent studies indicate that alveolar macrophages provide essential f
unctions that significantly enhance clearance of P. carinii infection. P. c
arinii also attaches to alveolar epithelial cells, causing inhibition of ep
ithelial growth and replication. In addition to cellular interactions, P. c
arinii organisms bind to a variety of host adhesive proteins present in the
lower respiratory tract. Binding of these proteins to P. carinii modulates
host cell recognition and immune responses to the parasite. During the cou
rse of P. carinii pneumonia, several inflammatory mediators are produced in
the lung. Although necessary for control of infection, exuberant inflammat
ory responses also predispose the host to the development of acute lung inj
ury. Thus, host defences against P. carinii depend on complex interactions
between immune and non-immune cells as well as several mediators that facil
itate host recognition and eventual elimination of infection. Understanding
these complex processes may enable development of novel therapeutic approa
ches for management of this important infection.